4-1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4-1BB agonists

Affiliations

• ¹ Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
• ² Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Tokyo Medical and Dental University, Tokyo, Japan.
• ³ Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California, United States.
• ⁴ Dartmouth Cancer Center, Hematology and Medical Oncology, Lebanon, New Hampshire, United States.
• ⁵ Labcorp Oncology, Durham, North Carolina, United States.
• ⁶ OmniSeq Incorporation, Buffalo, New York, United States.
• ⁷ Division of Surgical Oncology, Department of Surgery, Center for Personalized Cancer Therapy, University of California San Diego, La Jolla, California, United States.
• ⁸ Medical College of Wisconsin Cancer Center and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
• ⁹ Department of Oncology, Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States.
• ¹⁰ Department of Oncology, University of Nebraska, Omaha, Nebraska, United States.